Lansen Pharmaceutical Holdings Limited 朗生醫藥控股有限公司

Pay for financial year ended 2013-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

HKD '000

Directors

1 Chan, Michael Kee Huen 陳記煊 INED 32 32
2 Horlacher, Fritz Heinrich INED 29 29
3 Hunt, Stephen Burnau 韓仕德 NED, Ch 39 39
4 Lee, Jin Yi (1957-08-22) 李晉頤 NED, Dep Ch
5 Liu, Bang Min 劉幫民 CEO 179 16 195
6 Tang, Jun (Lansen) 湯軍 NED 8 8
7 Tang, Raymond Chiu Ping 鄧昭平 INED 32 32
8 Tao, Fang Fang 陶芳芳 NED
9 Xu, Jun (Lansen) 徐軍 CEO 40 3 43
10 Yip, Rebecca Pui Ling 葉佩玲 NED
Total 100 227 0 51 0 378

Main board pay history

Click on the year-end to see the pay details.

HKD'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2022-12-31 125 745 449 2 0 1,321 Report
2021-12-31 140 753 219 14 0 1,126 Report
2020-12-31 109 506 277 11 0 903 Report
2019-12-31 151 461 200 17 0 829 Report
2018-12-31 148 515 176 16 0 855 Report
2016-12-31 141 594 0 16 0 751 Report
2015-12-31 141 298 0 6 0 445 Report
2014-12-31 142 365 0 18 0 525 Report
2013-12-31 100 227 0 51 0 378 Report
2012-12-31 131 330 0 31 0 492 Report
2011-12-31 129 326 0 27 0 482 Report
2010-12-31 100 267 0 25 0 392 Report
Total 1,557 5,387 1,321 234 0 8,499

SGD'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2017-12-31 141 333 110 17 0 601 Report
Total 141 333 110 17 0 601

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top